(Q44350300)

2 December 2017

Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice (English)

1 reference

2 December 2017

0 references

Babette Kögel

1

1 reference

2 December 2017

Thomas Christoph

series ordinal

2

1 reference

2 December 2017

Wolfgang Strassburger

series ordinal

3

1 reference

2 December 2017

Elmar Friderichs

series ordinal

4

1 reference

2 December 2017

1 October 2005

1 reference

2 December 2017

European Journal of Pain

1 reference

2 December 2017

9

1 reference

2 December 2017

5

1 reference

2 December 2017

599-611

1 reference

Clinical actions of fentanyl and buprenorphine. The significance of receptor binding.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

The animal pharmacology of buprenorphine, an oripavine analgesic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Transdermal buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

A dosing nomogram for continuous infusion intravenous naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine: a review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Opioid rotation in the management of refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

HS-599: a novel long acting opioid analgesic does not induce place-preference in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine Blocks ϵ- and μ-Opioid Receptor-Mediated Antinociception in the Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Naloxone-associated morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Statistical analysis of drug-drug and site-site interactions with isobolograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Opioid rotation in chronic non-malignant pain patients. A retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Buprenorphine: Characteristics of binding sites in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

Ethical guidelines for investigations of experimental pain in conscious animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.02.002

10.1016/J.EJPAIN.2005.02.002

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference